A traditional herbal formula, Hyangsa-Pyeongwi san (HPS), improves quality of life (QoL) of the patient with functional dyspepsia (FD): Randomized double-blinded controlled trial

被引:48
作者
Kim, Jeung-Bae [1 ]
Shin, Jang-Woo [1 ]
Kang, Ji-Young [1 ]
Son, Chang-Gue [1 ]
Kang, Weechang [2 ]
Lee, Hye-Won [3 ]
Lee, Dong-Soo [4 ]
Park, Yang-Chun [1 ]
Cho, Jung-Hyo [1 ]
机构
[1] Daejeon Univ, Daejeon Oriental Hosp, Taejon 301724, South Korea
[2] Daejeon Univ, Coll Business Adm, Dept Business Informat Stat, Taejon 300716, South Korea
[3] Korea Inst Oriental Med, TKM Based Herbal Drug Res Grp, Taejon, South Korea
[4] Catholic Univ Korea, Daejeon St Marys Hosp, Dept Internal Med, Taejon, South Korea
关键词
Functional dyspepsia; Complementary and alternative medicine; Hyang-Sa-Pyeong-Wi-San; Quality of Life; IRRITABLE-BOWEL-SYNDROME; PLACEBO-CONTROLLED TRIAL; NONULCER DYSPEPSIA; NEPEAN DYSPEPSIA; DISORDERS; SCALE; PATHOPHYSIOLOGY; POPULATION; RESPONSES; EFFICACY;
D O I
10.1016/j.jep.2013.10.033
中图分类号
Q94 [植物学];
学科分类号
071001 [植物学];
摘要
Ethnopharmacological relevance: Hyangaa-Pyeongwi son is the most well known description in Traditional Chinese Medicine for treating functional gastrointestinal disorders. Functional dyspepsia (FD) is a main concern of intimidating quality of life (QoL) in recent days. Although many medicines have been developed to improve FD symptoms as well as QoL, there are no potential drugs and treatments for FD. The aim of this study is to investigate the effects of Hyangaa-Pyeongwi son (HPS) on QoL of patients with FD. Methods: This study was designed as a randomized, double blinded, placebo controlled, and parallel group trial. Participants received either placebo or HPS (9.68 g of HPS at once, three times daily) for 4-weeks, and the efficacy evaluations were performed by assessing the Nepean Dyspepsia Index (NDI) and functional dyspepsia-quality of life (FD-QoL) at 0-, 4- and 8-weeks. Results: Total of 170 patients participated and were randomly allocated into placebo or HPS groups. Total symptom score of NDI decreased after 4-weeks trial in both groups (p > 0.05). HPS significantly improved QoL scores, especially in the area of 'interference and eat/drink' in NDI (p=0.0031) as well as 'liveliness status', 'role-functioning status', and total score in FD-QoL (p=0.026 for liveliness status and p=0.035 for role-functioning status). This significant improvement of FD-QoL had lasted for 4-weeks. Conclusion: HPS treatment is markedly effective in improving QoL in patients with FD. Moreover, we observed that this improvement had lasted for 4 weeks after finishing the trial through the follow-up study. (C) 2013 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:279 / 286
页数:8
相关论文
共 33 条
[1]
IRRITABLE-BOWEL-SYNDROME AND DYSPEPSIA IN THE GENERAL-POPULATION - OVERLAP AND LACK OF STABILITY OVER TIME [J].
AGREUS, L ;
SVARDSUDD, K ;
NYREN, O ;
TIBBLIN, G .
GASTROENTEROLOGY, 1995, 109 (03) :671-680
[2]
Visceral hypersensitivity: facts, speculations, and challenges [J].
Camilleri, M ;
Coulie, B ;
Tack, JF .
GUT, 2001, 48 (01) :125-131
[3]
Cho Junghyo, 2010, [Journal of Physiology & Pathology in Korean Medicine, 동의생리병리학회지], V24, P22
[4]
Coon JT, 2002, ALIMENT PHARM THER, V16, P1689, DOI [10.1046/j.1365-2036.2002.01339.x, 10.1046/j.0269-2813.2002.01339.x]
[5]
Placebo responses and placebo effects in functional bowel disorders [J].
Enck, Paul ;
Horing, Bjoern ;
Weimer, Katja ;
Klosterhalfen, Sibylle .
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2012, 24 (01) :1-8
[6]
Anxiety, personality traits and quality of life in functional dyspepsia-suffering patients [J].
Filipovic, Branka F. ;
Randjelovic, Tomislav ;
Ille, Tatjana ;
Markovic, Olivera ;
Milovanovic, Branislav ;
Kovacevic, Nada ;
Filipovic, Branislav R. .
EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2013, 24 (01) :83-86
[7]
Froehlich F, 2001, AM J GASTROENTEROL, V96, P2329, DOI 10.1111/j.1572-0241.2001.04037.x
[8]
Efficacy of artichoke leaf extract in the treatment of patients with functional dyspepsia:: a six-week placebo-controlled, double-blind, multicentre trial [J].
Holtmann, G ;
Adam, B ;
Haag, S ;
Collet, W ;
Grünewald, E ;
Windeck, T .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2003, 18 (11-12) :1099-1105
[9]
A randomized placebo-controlled trial of simethicone and cisapride for the treatment of patients with functional dyspepsia [J].
Holtmann, G ;
Gschossmann, J ;
Mayr, P ;
Talley, NJ .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2002, 16 (09) :1641-1648
[10]
Functional (non-ulcer) dyspepsia: unexplained but not unmanageable [J].
Hu, WHC ;
Talley, NJ .
MEDICAL JOURNAL OF AUSTRALIA, 1998, 168 (10) :507-512